ϟ
DOI: 10.1093/annonc/mds172
¤ OpenAccess: Hybrid
This work has “Hybrid” OA status. This means it is free under an open license in a toll-access journal.
Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer
Claire F. Verschraegen,Sarah Czok,Carolyn Y. Muller,Leslie R. Boyd,S. J. Lee,Teresa Rutledge,Stephanie V. Blank,Bhavana Pothuri,S. Eberhardt,Muggia Fm
Medicine
Bevacizumab
Internal medicine
2012
Loading...
- MLA
- APA
- Chicago
- IEEE
- Harvard
- BibTeX
Cite this:
Generate Citation
“Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer” is a paper by Claire F. Verschraegen Sarah Czok Carolyn Y. Muller Leslie R. Boyd S. J. Lee Teresa Rutledge Stephanie V. Blank Bhavana Pothuri S. Eberhardt Muggia Fm published in 2012. It has an Open Access status of “hybrid”. You can read and download a PDF Full Text of this paper here.